MDRejuvena Secures $3 MIllion in Financing

MDRejuvena has secured a loan from Oxford Finance, a specialty finance firm, for the commercialization and continued development of the company’s Rejuvaphyl and daily skincare products.

The Rejuvaphyl line contains the proprietary and patented ingredient Phytochromatic MD Complex. Phytochromatic MD Complex is a naturally-derived, plant-based ingredient clinically proven to provide a number of important skincare benefits.

“MDRejuvena is led by a team of highly accomplished executives who have a successful track record in the skincare industry,” said Christopher A. Herr, senior managing director at Oxford Finance. “Oxford is pleased to provide funds to support the execution of the Company’s global marketing plan for its innovative product line.”

David F. Hale, executive chairman and chief executive officer of MDRejuvena stated, “We are excited about the opportunity to work with Oxford.  This financing will allow us to continue to build our business, expand our sales force into new markets, and develop our pipeline of new products.  Oxford’s support of MDRejuvena is an important step on the path to our success and will accelerate awareness of the MDRejuvena brand.”